1887

n South African Pharmaceutical and Cosmetic Review - News

Volume 39, Issue 9
  • ISSN : 0257-2028
USD

 

Abstract

Implications for future R&D in neuroscience


Ganitumab disappoints in pancreatic cancer
Clinical trials making the move to emerging countries
Inspection finds manufacturing deficiencies
R&D spending up, number of approved molecules down
Gilead taunts advocacy groups with Stribild pricing

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/im_sapcr/39/9/EJC125333
2012-09-01
2017-02-22

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error